2026: The methylation of the RANKL/OPG system is involved in fluorosis, and the effect of betaine supplementation

Recent Research
Post Reply
pfpcnews
Posts: 1317
Joined: Mon Apr 03, 2006 5:50 am

2026: The methylation of the RANKL/OPG system is involved in fluorosis, and the effect of betaine supplementation

Post by pfpcnews »

Wu W, Chen T, Tao N, Li PM, Gao MM, Wang M, Zhang XG, Tang L, Liu M, Liu J - "The methylation of the RANKL/OPG system is involved in fluorosis, and the effect of betaine supplementation" Sci Rep (2026)
https://doi.org/10.1038/s41598-026-75505-0
Abstract

This study aims to explore the role of DNA methylation in the promoter region of the RANKL/OPG on fluorosis and the effect of betaine supplementation. A case-control study of 82 paired cases and controls was conducted among residents in coal-burning fluorosis areas in Guizhou Province, China. RANKL and OPG levels in serum of particpants were measured using ELISA. In addition, 60 SD rats were randomly divided into five groups (n = 12): control group, model group, low-dose betaine group, medium-dose betaine group, and high-dose betaine group. 20 pairs case-control were randomly selected from 82 matched pairs to assess gene-specific DNA methylation. The methylation levels of RANKL/OPG in the human and rat whole blood were determined using targeted bisulfite sequencing (TBS). The expression of RANKL and OPG proteins in the femur tissues of rats was detected by Western blotting. The serum RANKL and OPG levels, and their ratios were elevated in the fluorosis patients compared with healthy individuals. A CpG site (pos651) in the OPG promoter exhibited hypomethylation in fluorosis patients, but this did not retain statistical significance after FDR correction(q > 0.05). Furthermore, betaine supplementation produced a dose-dependent reduction in dental fluorosis. Notably, dental fluorosis was present in 100% of the fluoride-exposed model group. Moreover, DNA methylation of CpG sites at pos1262, pos1289, pos1293, and pos1295 in the OPG gene of rat was reduced in the model group compared with the control group, and the methylation level was significantly restored in the betaine intervention group (P < 0.05). Additionally, long-term fluoride exposure upregulated the expression of RANKL and OPG proteins in bone tissues of the rats however, whereas betaine supplementation could reverse these changes dose-dependently (P < 0.05). Fluorosis may be associated with aberrant methylation of CpG sites in the OPG promoter. And betaine may potentially alleviate fluoride-induced bone changes, potentially through the regulation of the OPG/RANKL axis via epigenetic mechanisms.
admin
Site Admin
Posts: 7014
Joined: Tue Jan 18, 2005 10:25 pm

Re: 2026: The methylation of the RANKL/OPG system is involved in fluorosis, and the effect of betaine supplementation

Post by admin »

PFPC Commentary:

Thyroid hormone regulates RANKL expression and the RANKL/OPG system involved in bone remodeling.

NOTE: RANKL stands for Receptor Activator of Nuclear Factor Kappa-B Ligand. RANKL promotes the formation, activation, and survival of osteoclasts, the cells responsible for bone resorption. NF-Kappa B is downstream from Gq/11 activation.

Just a few studies here - there are many!

Konca Degertekin C, Turhan Iyidir O, Aktas Yılmaz B, Elbeg S, Pasaoglu OT, Pasaoglu H, Cakır N, Arslan M - "RANKL/Osteoprotegerin System and Bone Turnover in Hashimoto Thyroiditis" Calcif Tissue Int 99(4):365-72 (2016)
https://pubmed.ncbi.nlm.nih.gov/27328677/

Lademann F, Rijntjes E, Köhrle J, Tsourdi E, Hofbauer LC, Rauner M - "Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts" Commun Biol 7(1):548 (2024)
https://doi.org/10.1038/s42003-024-06227-0

Ma R, Morshed S, Latif R, Zaidi M, Davies TF - "The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis" Thyroid 21(8):897-906 (2011)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148120/

Martini G, Gennari L, De Paola V, Pilli T, Salvadori S, Merlotti D, Valleggi F, Campagna S, Franci B, Avanzati A, Nuti R, Pacini F - "The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels" Thyroid 18(4):455-60 (2008) doi: 10.1089/thy.2007.0166.
https://pubmed.ncbi.nlm.nih.gov/18399769/

Miura M, Tanaka K, Komatsu Y, Suda M, Yasoda A, Sakuma Y, Ozasa A, Nakao K - "A novel interaction between thyroid hormones and 1,25(OH)2D3 in osteoclast formation" Biochem Biophys Res Commun 291(4):987-994 (2002)
https://doi.org/10.1006/bbrc.2002.6561
Post Reply